DURECT Corporation

DURECT Corporationverified

DRRX

Price:

$1.91

Market Cap:

$59.31M

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-09-28

Stock Exchange

NASDAQ

Ticker

DRRX

The Enterprise Value as of November 2025 (TTM) for DURECT Corporation (DRRX) is 54.56M

According to DURECT Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 54.56M. This represents a change of 130.70% compared to the average of 23.65M of the last 4 quarters.

DURECT Corporation (DRRX) Historical Enterprise Value (quarterly & annually)

How has DRRX Enterprise Value performed in the past?

The mean historical Enterprise Value of DURECT Corporation over the last ten years is 200.45M. The current 54.56M Enterprise Value has changed 2.62% with respect to the historical average. Over the past ten years (40 quarters), DRRX's Enterprise Value was at its highest in in the December 2019 quarter at 725.99M. The Enterprise Value was at its lowest in in the December 2023 quarter at 8.78M.

Quarterly (TTM)
Annual

Average

200.45M

Median

148.80M

Minimum

7.84M

Maximum

668.46M

DURECT Corporation (DRRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of DURECT Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 929.70%

Maximum Annual Enterprise Value = 668.46M

Minimum Annual Increase = -86.62%

Minimum Annual Enterprise Value = 7.84M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202414.40M83.74%
20237.84M-86.62%
202258.59M-70.30%
2021197.26M-52.74%
2020417.38M-37.56%
2019668.46M929.70%
201864.92M-47.73%
2017124.19M-28.39%
2016173.42M-37.63%
2015278.04M166.12%

DURECT Corporation (DRRX) Average Enterprise Value

How has DRRX Enterprise Value performed in the past?

The current Enterprise Value of DURECT Corporation (DRRX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

26.94M

5-year avg

139.09M

10-year avg

200.45M

DURECT Corporation (DRRX) Enterprise Value vs. Peers

How is DRRX’s Enterprise Value compared to its peers?

DURECT Corporation’s Enterprise Value is greater than The Valens Company Inc. (-670000.00), greater than Safety Shot, Inc. (29.35M), greater than Zynerba Pharmaceuticals, Inc. (19.81M), less than Chicago Atlantic BDC, Inc. (779.19M), less than Heat Biologics, Inc. (20.56T), greater than Reneo Pharmaceuticals, Inc. (-21710584.00), greater than Achilles Therapeutics plc (-21604000.00), less than TCR2 Therapeutics Inc. (79.12M), greater than Lifeward Ltd. (13.13M), greater than Qilian International Holding Group Limited (31.78M),

Build a custom stock screener for DURECT Corporation (DRRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DURECT Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DURECT Corporation (DRRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DURECT Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is DURECT Corporation's Enterprise Value?

What is the highest Enterprise Value for DURECT Corporation (DRRX)?

What is the 3-year average Enterprise Value for DURECT Corporation (DRRX)?

What is the 5-year average Enterprise Value for DURECT Corporation (DRRX)?

How does the current Enterprise Value for DURECT Corporation (DRRX) compare to its historical average?